To view this notification widget you need to have JavaScript enabled.
Online Pharmacy Resource Portal for Pharmacists amp; Pre-Reg Pharmacists
 
Home
Pharmacy and Medical News
Clinical Pharmacy
Pharmacy Law and Ethics
Patient Counselling
Public Health & Health Promotion
Evidence-Based Medicine
Pharmacist
Pre-Reg Pharmacist

ResourceClinical - The Clinical Pharmacy and Drug Information Web Portal

Home > Pre-Reg Pharmacist > Over-the-counter (OTC) medicines to avoid in prostate enlargement

Download PDF format Download PDF format 

Over-the-counter (OTC) medicines to avoid in prostate enlargement


Below are some examples of medicines that can be found in OTC products that should be avoided or used with caution in patients with prostate enlargement, also known as benign prostatic hyperplasia (BPH), as they may precipitate urinary retention.

  • Antihistamines
    • Chlorphenamine
    • Promethazine
    • Cinnarizine
    • Meclozine
    • Triprolidine
    • Diphenhydramine
    • Buclizine
    • Doxylamine
  • Antimuscarinics
    • Hyoscine butylbromide
    • Hyoscine hydrobromide
  • Decongestants
    • Phenylephrine
    • Pseudoephedrine
    • Ephedrine
  • Phenothiazine
    • Prochlorperazine maleate

 

Site Map